nucleotide 2161 that predicts a lysine-to-asparagine substitution at amino acid position 656 in the extracellular domain (Lys^Asn) of the human leptin receptor (8) . We genotyped and performed association studies for these two polymorphisms in obese subjects referred to the Johns Hopkins University (JHU) Weight Management Center and in lean and obese subjects from the Baltimore Longitudinal Study on Aging (BLSA).
All protocols were approved by the Institutional Review Boards of the Johns Hopkins University and were performed after written informed consent had been obtained from the subjects. Since diabetes or its treatment may influence traits related to BMI and insulin resistance, studies were performed only in nondiabetic subjects. Between August 1994 and June 1996,175 Caucasian nondiabetic subjects 18 years of age or older were prospectively recruited from the JHU Weight Management Center. The group was 76.8% female, with a mean age of 42.8 ± 11.2 years and an average BMI of 36.7 ± 9.6 kg/m 2 (mean ± SD) (range 24.2-76.8). The BLSA is an open-ended study that began in 1958 and involves a self-recruited, highly educated, middle-and upperclass population, currently comprising -630 women and 750 men, ages 21-97 years. Extensive evaluations are performed on all entrants and include clinical, physiological, biochemical, psychological, and behavioral studies. Longitudinal changes are assessed by follow-up evaluations at 2-year intervals (9) . Potential candidates for our study were the 300 subjects with the lowest BMI (16.2-23.3 kg/m 2 ) and the 300 subjects with the highest BMI (26.7-46.5 kg/m 2 ). Those subjects who returned a signed consent form for the study by 1 January 1997 were included in the analysis. The lean group (n = 107) was 64.5% female, with a mean age of 56.7 ± 18.3 years and a mean BMI of 21.0 ± 1.4 kg/m 2 . The obese group (n = 104) was 40.3% female, with a mean age of 61.5 ± 13.5 years and a mean BMI of 30.5 ± 2.9 kg/m 2 . A 368-bp segment encompassing the site of the exon 4 polymorphism was generated from genomic DNA by polymerase chain reaction (PCR) using standard conditions with 5'-TCCTCTTTAAAAGCCTATCCAGTATTT-3' as the upstream primer and 5' -AGCTAGCAAATATTTTTGTAAGCAAT-3' as the downstream primer. PCR-restriction fragment length polymorphism (RFLP) analysis was performed using Msp I. The products expected after digestion were 368 bp for normal A 153-bp segment encompassing the site of the exon 12 polymorphism was generated from genomic DNA by PCR using standard conditions with 5'-GCATAAGTGTGTGCT TCAAATATGG-3' as the upstream primer and a mutagenic downstream primer (5' -CCAAAGTAAAGTGACATTTTTCGC-3') that selectively creates a Tha I site if the guanine-to-cytosine polymorphism is present (10 Asn polymorphisms, nor were any subjects homozygous for one polymorphism and heterozygous for the other polymorphism. These results indicate that no single haplotype contained both amino acid polymorphisms. Based on allele frequency of each polymorphism (see below), genotype frequencies did not differ significantly from those predicted by the Hardy-Weinberg rule.
In the obese JHU subjects, the allele frequency of the Gln 223 Arg polymorphism was 0.47. For the obese BLSA cases and lean BLSA control subjects, the allele frequencies were 0.41 and 0.45, respectively. By x 2 analysis, neither allele frequencies nor genotype frequencies for the Gln 223 Arg polymorphism were significantly different in the obese BLSA or JHU cases compared with the lean BLSA control subjects. Differences in quantitative phenotypic traits by genotype were determined by analysis of variance. No significant associations of the Gln 223 Arg polymorphism were found for BMI or traits related to obesity (waist-to-hip ratio, fasting and 2-h glucose levels, log of fasting and 2-h insulin levels during a 75-g oral glucose tolerance test) for obese JHU subjects, obese BLSA subjects, or lean BLSA subjects (Table 1) .
Similar to the Gln
223
Arg leptin receptor polymorphism, no significant differences in allele frequencies (obese JHU subjects, 0.16; obese BLSA subjects, 0.22; lean BLSA subjects, 0.17; NS) or in genotype frequencies for the Lys 656 Asn polymorphism were identified among the three groups. Furthermore, no significant associations between Lys^Asn genotype and obesity or traits related to obesity were present in any of the three groups.
In conclusion, our data indicate that the Gln 223 
Arg and Lys

656
Asn polymorphisms in the leptin receptor gene are found with similar frequencies in both lean and obese groups of Caucasians. Furthermore, in nondiabetic subjects, neither polymorphism associates with quantitative traits related to obesity, glucose tolerance, or insulin resistance. These studies provide evidence that the Gln Asn polymorphisms do not contribute significantly to the development of obesity in nondiabetic Caucasian subjects. Since phenotypic expression of a given gene variant may be dependent on genetic (ethnic) background, additional studies will be required to investigate the effect of these polymorphisms in other populations.
